Chlamydia Pneumoniae: Comparison with Findings of Mycoplasma Pneumoniae and Streptococcus Pneumoniae at Thin-Section CT

2007 ◽  
Vol 2007 ◽  
pp. 28-29
Author(s):  
M.L. Rosado de Christenson
2017 ◽  
Vol 34 (3) ◽  
pp. 128-134
Author(s):  
Md Abdus Salam ◽  
Md Robed Amin ◽  
Quazi Tarikul Islam

Introduction: Pneumonia is a worldwide, serious threat to health and an enormous socio-economic burden for health care system. According to recent WHO data, each year 3-4 million patients die from pneumonia. The clinical presentations and bacterial agents responsible for community acquired pneumonia (CAP) varies according to geography and culture.Methods: A cross sectional observational study conducted among the 53 consecutive patients with a clinical diagnosis of CAP in admitted patient in the department of Medicine, DMCH, during January 2010 to December 2010. Hematological measurements (TC of WBC, Hb%, ESR, platelet count), blood culture, chest X-ray P/A view, sputum for Gram staining and culture sensitivity, sputum for AFB, blood urea and random blood sugar were done in all cases. ELISA for IgM antibody of Mycoplasma pneumoniae and Chlamydia pneumoniae were done in sputum culture negative cases.Results: The mean (±SD) age was 38.9±17.3 years and Male female ratio was 3:1. Fever, chest pain and productive cough were the most common clinical features. The mean (±SD) respiratory rate was 23.0±2.8 /minute . COPD and DM were found in 17.0% and 5.7% of patients respectively . Blood culture was found positive in only 1.9% of the study patients. Gram positive Cocci 62.26%, Gram negative Bacilli 9.43%, mixed Gram positive cocci and Gram negative bacilli 11.32% and Gram negative Cocco Bacilli 1.9% were observed and in 15.03 % cases, no bacteria could be seen. Sputum culture revealed 53.8% streptococcus pneumoniae, 26.9% Klebsiella pneumonia as predominant organism. Mycoplasma pneumoniae and Chlamydia pneumoniae were found in 7.4% and 3.7% respectively by serological test. For Streptococcus pneumoniae, sensitive antibiotics were Amoxyclav and Levofloxacin. For Gram negative bacilli and coccobacilli, more sensitive antibiotics were Meropenem, Ceftriaxone, and Clarithromycin. The best sensitive drug were found meropenem. The mean (±SD) duration of hospital stay was 5.0±1.7 days with ranging from 3 to 10 days.Conclusion: Region based bacteroiological diagnosis of Cap is important for selecting the best and sensitive drugs for complete cure.J Bangladesh Coll Phys Surg 2016; 34(3): 128-134


2001 ◽  
Vol 58 (10) ◽  
pp. 575-581
Author(s):  
Herbert Dusch ◽  
M. G. Täuber

Die Pneumonie ist eine der wichtigsten Infektionskrankheiten. Die Liste der bekannten Erreger wurde durch die Entwicklung der mikrobiologischen Methoden in den letzten Jahren deutlich länger, doch bleiben die Pneumokokken (Streptococcus pneumoniae) unangefochten die Spitzenreiter der Häufigkeitsstatistik. Zur diagnostischen Abklärung einer Pneumonie wird bei stationären Patienten neben der Erhebung von Anamnese und klinischem Befund sowie der Durchführung eines Thoraxröntgen die Einsendung von Sputum, Blutkulturen, Urin und Nullserum an das mikrobiologische Labor empfohlen. Für ambulante Patienten kann der Laborteil zurückhaltender gehandhabt werden, aber ein Thorax-Röntgen ist zur Diagnose einer Pneumonie unverzichtbar. Wenn Sputumproben sachgerecht abgenommen, verarbeitet und interpretiert werden, können sie einen relevanten Beitrag zum Erstellen einer ätiologischen Diagnose leisten. Blutkulturen gestatten im positiven Fall eine sofortige Diagnose des ursächlichen Agens. Die Urinprobe dient zur Durchführung eines Antigentests auf Pneumokokken oder Legionellen. Bei beiden Tests steht ein vorläufiges Ergebnis bereits am selben Tag zur Verfügung. Das Nullserum wird im Labor vorerst nicht bearbeitet, sondern wird eingefroren und dient als Ausgangswert für eine Paralleluntersuchung zusammen mit einer späteren Serumprobe. Molekularbiologische Methoden gewinnen zunehmend an Bedeutung für den Nachweis von schwer kultivierbaren Erregern wie etwa Chlamydia pneumoniae oder Mycoplasma pneumoniae sowie auch für den Nachweis von respiratorischen Viren, allerdings sind sie noch nicht ausreichend standardisiert und stehen auch noch nicht kommerziell zur Verfügung.


2011 ◽  
Vol 9 (2) ◽  
Author(s):  
Rūta Nutautienė

Visuomenėje įgyta pneumonija (VĮP) pasaulyje sergama gana dažnai, o jos sukėlėjas nustatomas rečiau nei 50 proc. atvejų, ambulatoriškai gydomiems pacientams dažniausiai net netiriamas. Remiantis tyrimų duomenimis ir rekomendacijomis, dažniausiai VĮP gydyti antibiotikų skiriama empiriškai, taigi jie turi veikti Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, Chlamydia pneumoniae ir Legionella pneumophila. Makrolidai, ypač naujos kartos (azitromicinas), yra mažiau toksiški ir geresnes farmakokinetines savybes turintys alternatyvūs vaistai, vartotini, kai pacientas netoleruoja pirmos eilės vaisto. Klinikinių tyrimų rezultatai rodo, kad trijų dienų trukmės gydymas azitromicinu yra efektyvus ir saugus gydant viršutinių bei apatinių kvėpavimo takų infekcines ligas kasdienėje klinikinėje praktikoje.


1998 ◽  
Vol 9 (suppl e) ◽  
pp. 27E-29E
Author(s):  
Thomas J Marrie

Community-acquired pneumonia (CAP) is a common and a serious illness.Streptococcus pneumoniaeaccounts for about half of all cases of CAP. Atypical pneumonia, ie, pneumonia due toMycoplasma pneumoniae.Chlamydia pneumoniae.Legionespecies or viruses, is more common among patients treated on an ambulatory basis where these pathogens can collectively cause up to half of all cases of pneumonia. Changes in patient and microbe populations alter The epidemiology of pneumonia. Aspiration and Gram-negative rod pneumonia tend to be more common in nursing home populations. The emergence of macrolide- and beta-lactam-resistantS pneumoniaehas major implications for the approach to patients with CAP.


2013 ◽  
Vol 5 (2) ◽  
pp. 9 ◽  
Author(s):  
Shinsaku Imashuku ◽  
Naoko Kudo

There is a well-known correlation between <em>Herpes simplex</em> (HSV) infection and erythema multiforme (EM). More recently, in Japan, it was found that <em>Chlamydia pneumoniae </em>(Cp) may promote the development of EM. All cases of Cp infection-associated EM that had been diagnosed in our clinic over the past two years (from 2011 to 2012) were analyzed. Cp infection was diagnosed on the basis of a significant increase (&gt;2.00) in anti-Cp IgM titers, as measured by the HITAZYME-ELISA test. There were 7 cases of Cp-EM, one male and 6 females. Median age was 13 years (range 3-29 years). It is recommended that the possible involvement of Cp infection, besides HSV or <em>Mycoplasma pneumoniae</em> infections, should be considered in all cases of EM.


Radiology ◽  
2006 ◽  
Vol 238 (1) ◽  
pp. 330-338 ◽  
Author(s):  
Atsushi Nambu ◽  
Akitoshi Saito ◽  
Tsutomu Araki ◽  
Katsura Ozawa ◽  
Yoshimitsu Hiejima ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document